Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:06 PM
Ignite Modification Date:
2025-12-24 @ 10:06 PM
NCT ID:
NCT04475835
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years.
* Acute STEMI (including patients within 12 h of symptom onset, or 24-48 h with recurrent or ongoing chest pain chest pain, persistent ST-segment elevation or new left bundle branch block.
* Staged intervention of non-infarction related artery within 5 days after PPCI during Hospitalization.
* Signed informed consent.
Exclusion Criteria:
* Cardiogenic shock.
* Received thrombolytic therapy or used any anticoagulant drugs within 48 hours before randomized.
* Active bleeding, recent bleeding events or bleeding tendency.
* History of surgery in the last 1 month.
* Suspicious symptoms of aortic dissection, pericarditis and endocarditis.
* Blood pressure \> 180/110 mmHg.
* Hemoglobin \< 100 g/L, Platelet count \<100×10(9)/L, Transaminase 3 times upper limit of normality or Creatinine clearance \<30ml/min.
* History of Heparin-Induced Thrombocytopenia.
* Allergic to any research drug or device.
* Pregnancy or lactation.
* Any condition that makes the patient unsuitable for PCI or may interfere with the study.
* Patient disagrees or fails to sign the written informed consent.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04475835
Study Brief:
Protocol Section:
NCT04475835